ANDREW KONEN: Open Payments
NPI 1467439166 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$720 in 32 payments from 13 companies in 2025. Trend: 2023 $214 · 2024 $684 · 2025 $720
Food & beverage: $720
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 9 | $270 |
| ABBVIE INC. | 5 | $90 |
| Collegium Pharmaceutical, Inc. | 3 | $52 |
| Nalu Medical, Inc. | 4 | $52 |
| Abbott Laboratories | 2 | $41 |
| Globus Medical, Inc. | 2 | $40 |
| Bioventus LLC | 1 | $34 |
| Ethicon US, LLC | 1 | $33 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $28 |
| PFIZER INC. | 1 | $25 |
Products named: Intracept, UBRELVY, Artisan, XTAMPZA, Nalu Neurostimulation System, PROCLAIM, Senza, STRATAFIX.
Industry payments across TX — which companies pay providers there.
